[1]
Schlesinger, T., Bhatia, N., Berman, B., Grada, A., Torra, A., Cutler, D. and Lebwohl, M. 2020. Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s120. DOI:https://doi.org/10.25251/skin.4.supp.120.